These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35663939)

  • 1. Tumor-Resident T Cells, Associated With Tertiary Lymphoid Structure Maturity, Improve Survival in Patients With Stage III Lung Adenocarcinoma.
    Zhao H; Wang H; Zhao Y; Sun Q; Ren X
    Front Immunol; 2022; 13():877689. PubMed ID: 35663939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
    Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
    Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
    Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma.
    Wang D; Huang L; Qian D; Cao Y; Wu X; Xu P; Ming L; Tang J; Huang Z; Yin Y; Zhou L
    Front Immunol; 2023; 14():1334408. PubMed ID: 38259481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma.
    Wakasu S; Tagawa T; Haratake N; Kinoshita F; Oku Y; Ono Y; Takenaka T; Oda Y; Shimokawa M; Mori M
    Cancer Immunol Immunother; 2023 Jun; 72(6):1823-1834. PubMed ID: 36688996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD103
    Corgnac S; Malenica I; Mezquita L; Auclin E; Voilin E; Kacher J; Halse H; Grynszpan L; Signolle N; Dayris T; Leclerc M; Droin N; de Montpréville V; Mercier O; Validire P; Scoazec JY; Massard C; Chouaib S; Planchard D; Adam J; Besse B; Mami-Chouaib F
    Cell Rep Med; 2020 Oct; 1(7):100127. PubMed ID: 33205076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating Tumor-Associated Tertiary Lymphoid Structures in Murine Lung Adenocarcinoma.
    Connolly KA; Nader M; Joshi N
    Methods Mol Biol; 2018; 1845():259-273. PubMed ID: 30141018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution and maturation of tertiary lymphoid structures can predict clinical outcomes of patients with gastric adenocarcinoma.
    Sun H; Liu Y; Cheng W; Xiong R; Gu W; Zhang X; Wang X; Wang X; Tan C; Weng W; Zhang M; Ni S; Huang D; Xu M; Sheng W; Wang L
    Front Immunol; 2024; 15():1396808. PubMed ID: 39136032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
    Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
    Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer.
    Xiaoxu D; Min X; Chengcheng C
    BMC Pulm Med; 2024 Mar; 24(1):155. PubMed ID: 38532454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma.
    Xu X; Gao Y; Duan S; Ding Q; Wang X; Dai X; Zhang Y; Chen Y; Chen D
    Cancer Med; 2023 Apr; 12(8):9547-9558. PubMed ID: 36880167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem-like cells evade CD8
    Corgnac S; Damei I; Gros G; Caidi A; Terry S; Chouaib S; Deloger M; Mami-Chouaib F
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35418483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma.
    Matsuda N; Yamamoto H; Habu T; Iwata K; Matsubara K; Tanaka S; Hashimoto K; Shien K; Suzawa K; Miyoshi K; Toji T; Okazaki M; Sugimoto S; Takahashi K; Toyooka S
    Ann Surg Oncol; 2023 Dec; 30(13):8727-8734. PubMed ID: 37658268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial features of specific CD103
    Yang G; Cai S; Hu M; Li C; Yang L; Zhang W; Sun J; Sun F; Xing L; Sun X
    J Transl Med; 2024 Jan; 22(1):27. PubMed ID: 38183111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer.
    Workel HH; van Rooij N; Plat A; Spierings DCJ; Fehrmann RSN; Nijman HW; de Bruyn M
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of immunogenic cell death-inducing chemotherapeutics on the immune cell activation and tertiary lymphoid structure formation in melanoma.
    Zhao H; Zhao Y; Zhang S; Wang Z; Yu W; Dong N; Yang X; Zhang X; Sun Q; Hao X; Ren X
    Front Immunol; 2024; 15():1302751. PubMed ID: 38384466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
    Ling Y; Zhong J; Weng Z; Lin G; Liu C; Pan C; Yang H; Wei X; Xie X; Wei X; Zhang H; Wang G; Fu J; Wen J
    Clin Transl Med; 2022 Oct; 12(10):e1074. PubMed ID: 36245289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.